Skip to main content
. 2016 Dec 20;34(2):495–512. doi: 10.1007/s12325-016-0464-9

Table 4.

Overall survival curve adjustment to dacarbazine reference: HR and adjustment factor for all patients (stage IIIB–IV M1c)

Trial (drug, patient population) HR for comparators HR for dacarbazine Adjustment factor
OPTiM (GM-CSF, previously treated and untreated) [11] 0.22 0.32 1.46
MDX010-20 (gp100, previously treated) [7] 0.34 0.32 0.95

GM-CSF granulocyte-macrophage colony-stimulating factor, gp100 glycoprotein 100, HR hazard ratio